In my bracketed annotations in message #21457 (today’s WSJ cover story on PFE), I erroneously stated that lovastatin was generic Zocor; in fact, it is generic Mevacor, an older and weaker statin developed by Merck that has been off-patent for several years.
Market Data 
Markets 
AI
